Process for the production of a crystalline glucagon receptor antagonist compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8232413
APP PUB NO 20100184995A1
SERIAL NO

12675990

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a process for the production of crystalline particles of a glucagon receptor antagonist compound. The process includes the steps of generating microseeds and subjecting the microseeds to a crystallization process. The resulting crystalline particles have a mean particle size of less than about 100 mm. The present invention also provides for a pharmaceutical composition which includes the crystalline particles produced by the method described herein and a pharmaceutically acceptable carrier.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME LLC126 E LINCOLN AVE RAHWAY NJ 07065

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cohen, Benjamin M Cranford, US 28 246
Cote, Aaron S West Windsor, US 12 93
Kumke, Daniel J Colts Neck, US 5 31
Tan, Lushi Edison, US 25 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation